Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: plyd...

plyd...

posted on Apr 24, 2007 09:28AM

Please tell Mr Pohl that we don't need any more dividends.. certainly not at this time..  I do not believe Swartz/Lincoln need to be given any more money from the coffers of PTSC.. unless it is to buy en mass warrants from them.  That money, that would be paid out in dividends, would much better suit the company and its retail shareholders if it were saved, and then put to use to increase future revenues, as in merger or aquisition.. with the goal of getting the 'f' off the OTC.

Thank you, and tell DP to shoot me an email...

Share
New Message
Please login to post a reply